Pinnacle Holdings LLC bought a new stake in Merck KGaA (OTCMKTS:MKGAF – Free Report) in the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund bought 11,571 shares of the company’s stock, valued at approximately $1,487,000.
Several other hedge funds also recently modified their holdings of MKGAF. Frazier Financial Advisors LLC bought a new position in shares of Merck KGaA during the 2nd quarter valued at $25,000. Rakuten Securities Inc. bought a new stake in Merck KGaA in the second quarter worth $27,000. Bard Associates Inc. bought a new position in Merck KGaA during the second quarter valued at about $60,000. Kilter Group LLC acquired a new position in shares of Merck KGaA during the 2nd quarter valued at about $62,000. Finally, Addison Advisors LLC bought a new stake in Merck KGaA during the second quarter worth approximately $90,000. Institutional investors and hedge funds own 0.10% of the company’s stock.
Merck KGaA Stock Performance
OTCMKTS:MKGAF opened at $163.21 on Monday. The company has a quick ratio of 0.84, a current ratio of 1.31 and a debt-to-equity ratio of 0.27. The company’s 50 day moving average is $162.62 and its 200-day moving average is $148.44. The firm has a market cap of $21.09 billion, a price-to-earnings ratio of 24.92 and a beta of 0.96. Merck KGaA has a 12 month low of $116.68 and a 12 month high of $175.56.
About Merck KGaA
Merck KGaA, headquartered in Darmstadt, Germany, is a long-established multinational chemical and pharmaceutical company with roots dating back to 1668. Operating under the brand Merck Group (and using distinct consumer-facing names in certain regions to avoid confusion with other companies of similar name), the company is privately controlled by the Merck family and organizes its activities across multiple business units that serve customers in Europe, the Americas, Asia-Pacific and beyond.
The company’s operations are organized mainly into three businesses.
Featured Stories
- Five stocks we like better than Merck KGaA
- VIG, VYM, and VYMI: Which Vanguard Dividend ETF Is Right for You?
- 3 Closed-End Funds to Maximize Dividend Payments
- Rocket Lab’s Sell-Off Is Fading—Is It Finally Safe to Buy?
- $27 Billion in Buybacks: 3 Stocks Betting Their Strong Runs Aren’t Over
Want to see what other hedge funds are holding MKGAF? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Merck KGaA (OTCMKTS:MKGAF – Free Report).
Receive News & Ratings for Merck KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merck KGaA and related companies with MarketBeat.com's FREE daily email newsletter.
